|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-IOR-17011151 |
|
Date of registration:
|
2017-04-16 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The comparative study of ropivacaine and bupivacaine with fentanyl for labor analgesia under combined spinal and epidural analgesia
|
|
Scientific title:
|
The comparative study of ropivacaine and bupivacainewith fentanyl for labor analgesia under combined spinal and epidural analgesia |
|
Date of first enrolment:
|
2017-05-01 |
|
Target sample size:
|
group A:50;group B:50; |
|
Recruitment status: |
Pending |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=18781 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Other
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Changting Yan
|
|
Address:
|
129 West Zhenxing Road, Liaocheng, Shandong, China
|
|
Telephone:
|
+86 13563503398 |
|
Email:
|
yctsea@163.com |
|
Affiliation:
|
Liaocheng Dongchangfu District Health Center for Women & Children |
|
|
Name:
|
Changting Yan
|
|
Address:
|
129 West Zhenxing Road, Liaocheng, Shandong, China
|
|
Telephone:
|
+86 13563503398 |
|
Email:
|
yctsea@163.com |
|
Affiliation:
|
Liaocheng Dongchangfu District Health Center for Women & Children |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: This study included nulliparous parturients at greater than 37 weeks of gestation and with a cervical dilation of 3cm, ASA physical status I and II, request for labor analgesia, more than 18 year old, no sign for cesarean section, full-term pregnancy without any contraindications to neuraxial anesthesia.
Exclusion criteria: Parturients were excluded if they were less than18 year-old, allergy to any study drugs or had Contraindications to neuraxial anesthesia and obstetric factors are not suitable for vaginal delivery, previous cesarean delivery.
Age minimum:
18
Age maximum:
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
vaginal delivery
|
|
Intervention(s)
|
|
group A:2 ml of 0.125% bupivacaine plus 5 ug fentanyl for spinal anesthesia, 0.125% bupivacaine with 2 ug/mL fentanyl by PCEA;group B:2 ml of 0.125% ropivacaine plus 5 ug fentanyl for spinal anesthesia, 0.125% ropivacaine with 2 ug/mL fentanyl by PCEA;
|
|
Primary Outcome(s)
|
|
MMT;Analgesic effect;
|
|
Secondary Outcome(s)
|
|
general condition;Non-invasive Blood Pressure;Heart Rate;labor condition;Apgar Score;
|
|
Source(s) of Monetary Support
|
|
Hospital department development fund
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|